Sales: CHF1.013 billion, a 1% increase in local currencies. EBITDA Before Exceptional Items: CHF190 million, a 3% increase, with a margin improvement of 70 basis points to 18.8%. Cost Savings Program: Completed CHF175 million program; new CHF80 million program by 2027, with CHF3 million savings achieved in Q1. Lucas Meyer Cosmetics Sales: CHF25 million with high profitability. Care Chemicals EBITDA: CHF130 million, margin of 21.7%. Catalyst Sales Decline: 13% in local currency and Swiss francs. Absorbents and Additives Sales Increase: 2% in both local currency and Swiss francs. Reported EBITDA: CHF152 million, a 12% decrease, with a margin of 15.0% including CHF38 million restructuring charges. 2025 Guidance: Sales growth at the lower end of 3% to 5% range; EBITDA margin improvement to 17%-18% before exceptional items. Warning! GuruFocus has detected 4 Warning Signs with CLZNF. Release Date: April 29, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Clariant AG (CLZNF) reported a 1% increase in sales in local currencies, reaching CHF1.013 billion, indicating stable performance. EBITDA before exceptional items increased by 3% to CHF190 million, with a margin improvement of 70 basis points to 18.8%. The company completed a CHF175 million cost savings program, enhancing operating leverage and supporting margin improvement. Lucas Meyer Cosmetics delivered strong operational performance with sales of CHF25 million and high profitability, receiving six innovation awards. Clariant AG (CLZNF) maintains a resilient business model with a well-balanced regional sourcing and production footprint, mitigating direct impacts from tariffs and trade tensions. Negative Points Organic volumes decreased by 2% overall, with declines in the Catalysts segment offsetting growth in other areas. Catalyst sales declined by 13% in local currency due to weak economic conditions and low utilization rates. Reported EBITDA decreased by 12% to CHF152 million, impacted by CHF38 million in restructuring charges. The company faces increased uncertainty due to tariffs and trade tensions, which could negatively impact global demand and consumer sentiment. Clariant AG (CLZNF) anticipates sales growth at the lower end of the 3% to 5% range, reflecting a cautious outlook amid uncertain market conditions. Q & A Highlights Q: Can you provide more details on the profitability of Lucas Meyer Cosmetics and the demand trends in Q1? A: Conrad Keijzer, CEO, stated that Lucas Meyer Cosmetics achieved high single-digit sales growth and maintained strong profitability with EBITDA margins between 45% and high 40s. The quarter followed a usual pattern with a strong finish in March, particularly in Additives, without significant pre-buying effects. Story Continues Q: What are the expectations for the Catalyst division, given the volume decline? A: Conrad Keijzer, CEO, explained that the Catalyst division is currently operating at 70% to 80% capacity utilization. The company does not expect a significant pickup in Catalyst demand this year, with volumes likely to remain similar to last year, gradually building up from quarter to quarter. Q: How is Clariant addressing tariff impacts, and what are the expectations for Chinese PDH demand? A: Conrad Keijzer, CEO, mentioned that Clariant's local production strategy mitigates direct tariff impacts. For Chinese PDH demand, customers are shifting propane sourcing from the US to the Middle East due to tariffs. The company expects more exemptions for chemicals, which are intermediate products. Q: Can you discuss the trends in raw materials and pricing, and how they compare to tariffs? A: Conrad Keijzer, CEO, noted a 1% increase in raw material costs year-on-year, with pricing remaining flat in some segments. While energy prices have eased, tariffs are causing inflation. Clariant anticipates a 1% to 2% increase in raw materials for the year, balancing easing energy costs and tariff-induced inflation. Q: What is the outlook for Clariant's Absorbents and Additives (A&A) growth in a challenging macro environment? A: Conrad Keijzer, CEO, stated that while Additives are on track with double-digit growth, Absorbents need improvement. The company expects stronger A&A performance throughout the year, driven by renewable diesel demand and the startup of a new plant in Quincy. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. View Comments
Clariant AG (CLZNF) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Market Challenges
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...